Thoracic Vascular Stent Grafts Market Size & Share, by Type (Plastic, Metal); Product Type (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular); Application (Cardiac Aneurysm, Cardiovascular Diseases, Kidney Failure); End-user (Hospitals, Ambulatory Surgical Centers, Medical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4304
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Thoracic Vascular Stent Grafts Landscape

top-features-companies
    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • JOTEC GmbH
    • Cook Group Incorporated
    • Terumo Corporation
    • Cardinal Health, Inc.
    • LeMaitre Vascular, Inc.
    • Merit Medical Systems, Inc.
    • Lombard Medical Ltd
    • Lifetech Scientific (Shenzhen) Co., Ltd.
    • Endologix LLC

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Terumo Corporation has launched the Thoraflex Hybrid Device for the treatment of complex aortic arch disease. The single-use device is comprised of a Gelweave polyester graft coupled to a Nitinol self-expanding stent.

  • Lifetech Scientific (Shenzhen) Co., Ltd. has attained a formal written notice from the National Medical Products Administration (“NMPA”) authorizing the admission of the Artery Stent Graft System (chimney technology) into the NMPA Special Examination and Approval Procedure for Innovative Medical Services. This is the world's first stent graft system engineered specifically for "chimney technology", a mainstream technology for treating aortic dissection lesions.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4304
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing geriatric population, growing cases of hypertension, increasing consumption of tobacco, and upsurge in fast food consumption are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

High cost of thoracic vascular stent grafts treatment, growing acceptance of balloon angioplasty, and associated hurdles with thoracic stent grafts are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic, JOTEC GmbH, Cook Group Incorporated, Terumo Corporation, Cardinal Health, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, product type, application, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying